ALZCUR — AlzeCure Pharma AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK229.25m
- SEK172.90m
Annual cashflow statement for AlzeCure Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -71.6 | -77.9 | -56.4 | -38.3 | -36.1 |
| Depreciation | |||||
| Non-Cash Items | 0.214 | 0.146 | 0.207 | 1.1 | 0.929 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.36 | 6.57 | -44.2 | 39.7 | -0.201 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -69.5 | -70.6 | -99.9 | 3.06 | -35.1 |
| Capital Expenditures | -0.671 | -0.054 | 0 | — | -0.124 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | 0.007 | 0 |
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | -0.671 | -0.054 | 0 | 0.007 | -0.124 |
| Financing Cash Flow Items | — | — | — | 0.039 | -6.91 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 0.114 | 0 | 83.7 | 0.459 | 37.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -70.1 | -70.7 | -16.2 | 3.52 | 2.4 |